| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An Australian perspective on monkeypox virus and stool transplants
|
Koh, Bryant
|
|
|
8 |
2 |
p. 114-115
|
artikel
|
| 2 |
An open letter to Gavi: hepatitis B birth dose vaccine can't wait
|
|
|
|
8 |
2 |
p. 115-116
|
artikel
|
| 3 |
Another arrow in the NASH quiver?
|
Forlano, Roberta
|
|
|
8 |
2 |
p. 96-97
|
artikel
|
| 4 |
An unusual complication after a variceal glue injection
|
Morgan, James A
|
|
|
8 |
2 |
p. 198
|
artikel
|
| 5 |
Correction to Lancet Gastroenterol Hepatol 2023; 8: 81–94
|
|
|
|
8 |
2 |
p. 117
|
artikel
|
| 6 |
Faecal microbiota transplantation for first and second episodes of Clostridioides difficile infection
|
Krutova, Marcela
|
|
|
8 |
2 |
p. 111-112
|
artikel
|
| 7 |
Faecal microbiota transplantation for first and second episodes of Clostridioides difficile infection
|
van Prehn, Joffrey
|
|
|
8 |
2 |
p. 109
|
artikel
|
| 8 |
Faecal microbiota transplantation for first and second episodes of Clostridioides difficile infection
|
Goldenberg, Simon D
|
|
|
8 |
2 |
p. 109-110
|
artikel
|
| 9 |
Faecal microbiota transplantation for first and second episodes of Clostridioides difficile infection
|
Aby, Elizabeth S
|
|
|
8 |
2 |
p. 110-111
|
artikel
|
| 10 |
Faecal microbiota transplantation for first and second episodes of Clostridioides difficile infection – Authors' reply
|
Baunwall, Simon Mark Dahl
|
|
|
8 |
2 |
p. 112-113
|
artikel
|
| 11 |
Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial
|
Ghaneh, Paula
|
|
|
8 |
2 |
p. 157-168
|
artikel
|
| 12 |
Lessons and open questions in borderline resectable pancreatic cancer
|
Reni, Michele
|
|
|
8 |
2 |
p. 101-102
|
artikel
|
| 13 |
Living
|
Barker, George
|
|
|
8 |
2 |
p. 119
|
artikel
|
| 14 |
Local and systemic therapy in liver cancer: the quest for synergy
|
Pinter, Matthias
|
|
|
8 |
2 |
p. 102-104
|
artikel
|
| 15 |
Low intensity treatment in metastatic colorectal cancer
|
Wong, Hui-Li
|
|
|
8 |
2 |
p. 97-99
|
artikel
|
| 16 |
Mechanisms and possible hepatoprotective effects of glucagon-like peptide-1 receptor agonists and other incretin receptor agonists in non-alcoholic fatty liver disease
|
Targher, Giovanni
|
|
|
8 |
2 |
p. 179-191
|
artikel
|
| 17 |
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study
|
Liu, Zhigang
|
|
|
8 |
2 |
p. 145-156
|
artikel
|
| 18 |
New hepatitis B drug development disillusions: time to reset?
|
Pawlotsky, Jean-Michel
|
|
|
8 |
2 |
p. 192-197
|
artikel
|
| 19 |
Palliative care in advanced liver disease: time for action
|
Verma, Sumita
|
|
|
8 |
2 |
p. 106-108
|
artikel
|
| 20 |
Peroral endoscopic myotomy versus pneumatic dilation in treatment-naive patients with achalasia
|
Zhang, Fei
|
|
|
8 |
2 |
p. 113-114
|
artikel
|
| 21 |
Peroral endoscopic myotomy versus pneumatic dilation in treatment-naive patients with achalasia – Authors' reply
|
Kuipers, Thijs
|
|
|
8 |
2 |
p. 114
|
artikel
|
| 22 |
Research in Brief
|
Baker, Holly
|
|
|
8 |
2 |
p. 118
|
artikel
|
| 23 |
Safety, pharmacokinetics, and pharmacodynamics of pegozafermin in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 1b/2a multiple-ascending-dose study
|
Loomba, Rohit
|
|
|
8 |
2 |
p. 120-132
|
artikel
|
| 24 |
Sequential transarterial chemoembolisation and stereotactic body radiotherapy followed by immunotherapy as conversion therapy for patients with locally advanced, unresectable hepatocellular carcinoma (START-FIT): a single-arm, phase 2 trial
|
Chiang, Chi Leung
|
|
|
8 |
2 |
p. 169-178
|
artikel
|
| 25 |
Tackling the burden of digestive disorders in Europe
|
The Lancet Gastroenterology & Hepatology,
|
|
|
8 |
2 |
p. 95
|
artikel
|
| 26 |
Terlipressin for hepatorenal syndrome: opportunities and challenges
|
Singal, Ashwani K
|
|
|
8 |
2 |
p. 104-106
|
artikel
|
| 27 |
Trifluridine–tipiracil plus bevacizumab versus capecitabine plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer ineligible for intensive therapy (SOLSTICE): a randomised, open-label phase 3 study
|
André, Thierry
|
|
|
8 |
2 |
p. 133-144
|
artikel
|
| 28 |
Working towards a comprehensive appraisal of vaccine-induced immunity against SARS-CoV-2 in IBD
|
Otten, Antonius T
|
|
|
8 |
2 |
p. 99-100
|
artikel
|
Tijdschrift beschrijving